HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Michel Michaelides Selected Research

Guanylate Cyclase-Activating Proteins

1/2011Dominant cone-rod dystrophy: a mouse model generated by gene targeting of the GCAP1/Guca1a gene.
8/2005Mutation in the gene GUCA1A, encoding guanylate cyclase-activating protein 1, causes cone, cone-rod, and macular dystrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Michel Michaelides Research Topics

Disease

8Retinitis Pigmentosa (Pigmentary Retinopathy)
03/2015 - 09/2005
8Macular Degeneration (Age-Related Maculopathy)
03/2013 - 05/2003
7Atrophy
06/2014 - 08/2005
6Color Vision Defects (Color Blindness)
01/2016 - 07/2010
6Macular Edema
03/2015 - 03/2010
4Diabetic Retinopathy (Retinopathy, Diabetic)
01/2014 - 05/2010
3Retinal Dystrophies
12/2013 - 03/2008
2Eye Diseases (Eye Disease)
01/2016 - 02/2013
2Blindness (Hysterical Blindness)
05/2015 - 01/2014
2Retinal Degeneration
11/2014 - 01/2011
2Optic Atrophy
01/2014 - 01/2010
2Myopia
02/2013 - 04/2009
1Photophobia (Light Sensitivity)
01/2016
1Choroidal Neovascularization
03/2014
1Central Serous Chorioretinopathy
03/2014
1Albinism
12/2013
1Ganglion Cysts (Ganglion)
12/2012
1Leber Congenital Amaurosis
01/2012
1Disease Progression
01/2011
1Body Weight (Weight, Body)
01/2011
1Ischemia
06/2010
1Infection
03/2010
1Hepatitis C
03/2010
1Entropion
02/2010
1Retinal Diseases
01/2010
1Amelogenesis Imperfecta
02/2009
1Hearing Loss (Hearing Impairment)
03/2008
1Dry Eye Syndromes (Dry Eye Syndrome)
06/2007
1Glaucoma
01/2007
1Cataract (Cataracts)
01/2007
1Retinal Perforations
08/2006

Drug/Important Bio-Agent (IBA)

24Retinaldehyde (Retinal)IBA
01/2016 - 08/2005
4bevacizumabFDA Link
09/2013 - 05/2010
2Cone OpsinsIBA
11/2014 - 07/2010
2AC133 antigen (prominin)IBA
02/2011 - 08/2008
2Guanylate Cyclase-Activating ProteinsIBA
01/2011 - 08/2005
1Blue cone monochromatismIBA
01/2016
1Carbonic Anhydrase InhibitorsIBA
03/2015
1lecithin-retinol acyltransferaseIBA
01/2015
1Achromatopsia 3IBA
12/2013
1OpsinsIBA
02/2013
1Cyclic GMPIBA
01/2011
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2011
1Posterior column ataxiaIBA
11/2010
1Rod OpsinsIBA
07/2010
19-cis-retinalIBA
07/2010
1Fluorescein (Funduscein)FDA LinkGeneric
05/2010
1Interferon-alpha (Interferon Alfa)FDA Link
03/2010
1Ribavirin (Virazole)FDA LinkGeneric
03/2010
1InterferonsIBA
03/2010
1Tetracaine (Amethocaine)FDA LinkGeneric
02/2010
1Proteins (Proteins, Gene)IBA
01/2010
1Nonsense Codon (Nonsense Mutation)IBA
01/2010
1Auditory neuropathyIBA
01/2010
1DNA (Deoxyribonucleic Acid)IBA
04/2009
1Amaurosis hypertrichosisIBA
02/2009
1Mitochondrial DNA (mtDNA)IBA
03/2008
1CanaliculitisIBA
06/2007
1peripherinIBA
09/2005
1North Carolina type 1 retinal Macular dystrophyIBA
05/2003

Therapy/Procedure

4Laser Therapy (Surgery, Laser)
09/2013 - 05/2010
1Sutures (Suture)
02/2010
1Laser In Situ Keratomileusis (LASIK)
06/2007
1Intraocular Lenses (Intraocular Lens)
01/2007